Dr. Kenneth Kim of WCCT Coauthors Research Paper In The Journal of Clinical Pharmacology

Tuesday, February 09, 2010 / Cypress, CA

West Coast Clinical Trials, LLC announced today that Dr. Kenneth Kim, CEO (WCCT.com) was a coauthor of a paper entitled “Lack of Racial Differences in the Pharmacokinetics of Subcutaneous Golimumab in Healthy Japanese and Caucasian Male Subjects“, which appeared in the February, 2010 issue of The Journal of Clinical Pharmacology.

About West Coast Clinical Trials, LLC

West Coast Clinical Trials (WCCT) is a private minority-owned independent Phase I-IV Clinical Research Organization located in Southern California. WCCT has 150 beds in two locations, over 40,000 square feet, and a well-trained and experienced staff bringing the highest quality to the pharmaceutical and biotechnology industries.

WCCT was founded by Dr. Kenneth Kim who is board certified in Internal Medicine and Allergy and Immunology. WCCT has been conducting trials since 1998 and has been audited by the FDA and numerous pharmaceutical and biotechnology companies. Our location and access to an ethnically diverse population allows us to conduct a wide variety of studies designs including ethnic bridging, and specialty trials.

Contact information:

West Coast Clinical Trials
5630 Cerritos Ave.
Cypress, CA 90630 USA
Phone: (714) 252-0700
E-mail: mgr@wcctrials.com
http://wcct.com